TICAM1 and psoriasis: A decoy peptide called MIP2 designed from the αC helix of TIRAP also blocks both MyD88 and TRIF-dependent TLR4 downstream signaling to exert a protective action in the psoriasis animal model (Shah et al., 2020[189]).